<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[therapy 2000 inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/therapy+2000+inc..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to therapy 2000 inc.]]></description>
	<s:counts start="0" returned="20" found="35" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Books, Software, and Videotapes Received]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb237/is_6_81/ai_n28845885]]></link>
		<description><![CDATA[Books, software, and videotapes received for review by the Journal Editorial Office are listed in Physical Therapy on a quarterly basis. The items noted below were received between January 1, 2001, and March 31, 2001. Reviews of many of these items will appear in upcoming issues.  Activities for Older...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Jun 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lippincott+williams+%2526+wilkins+inc..html"><![CDATA[Lippincott Williams & Wilkins Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Books, Software, and Videotapes Received]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb237/is_3_81/ai_n28831290]]></link>
		<description><![CDATA[Books, software, and videotapes received for review by the Journal Editorial Office are listed in Physical Therapy on a quarterly basis. The items noted below were received between October 1, 2000, and December 31, 2000. Reviews of many of these items will appear in upcoming issues.  The Athletic Trainer's...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Mar 2001 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/haworth+press+inc..html"><![CDATA[Haworth Press Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[DUSA Pharmaceuticals Updates Investors at JP Morgan H&Q Healthcare Conference; Announces 100 BLU-U Contracts Signed During Q4 2000]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_Jan_10/ai_68975347]]></link>
		<description><![CDATA[Business Editors, Health/Medical Writers  WILMINGTON, Mass.--BW HealthWire--Jan. 10, 2001  DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) updated investors today at the JP Morgan H&Q Healthcare Conference in San Francisco.  Dr. Geoffrey Shulman, DUSA's President and CEO, and Dr. Stuart Marcus, the Company's VP, Scientific Affairs and CSO, discussed progress in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 10 Jan 2001 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/dusa+pharmaceuticals+inc..html"><![CDATA[DUSA Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DUSA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="tickers">DUSA,JPM</category>
	</item>
	<item>
		<title><![CDATA[BIOTRONIK Announces First Investigational Implant of the Tachos DR ICD with Atrial Therapy]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Dec_22/ai_68368462]]></link>
		<description><![CDATA[Business Editors  LAKE OSWEGO, Ore.--BUSINESS WIRE--Dec. 22, 2000  Biotronik, Inc. announced today the first investigational implant of the Tachos DR ICD with Atrial Therapy.  This device represents a significant milestone in the treatment of arrhythmias in both the atrium and ventricle. The Tachos DR ICD with Atrial...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 22 Dec 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotronik+inc..html"><![CDATA[Biotronik Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Cardiac Science Awarded U.S. Patent for Unique Defibrillation Electrodes]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Dec_19/ai_68203608]]></link>
		<description><![CDATA[Business Editors and Health/Medical Writers  BIOWIRE2K  IRVINE, Calif.--BW HealthWire--Dec. 19, 2000  12 Other Patent Applications Filed Over the Past Year to Secure  Technology Platform and Recurring Revenue Stream  Cardiac Science Inc., (Nasdaq:DFIB), the developer of the only patient monitoring technology that provides life-saving external defibrillation...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 19 Dec 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cardiac+science+inc..html"><![CDATA[Cardiac Science Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CPMP recommends approval in Europe for Visudyne therapy in the treatment of pathologic myopia.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200012/ai_n22601751]]></link>
		<description><![CDATA[ATLANTA, GA and VANCOUVER, BC, Dec 15, 2000    CIBA Vision Corporation, the eye care unit of Novartis AG (NYSE:  NVS), and QLT Inc.(NASDAQ: QLTI; TSE:QLT) announced today that the  Committee for Proprietary Medicinal Products CPMP of the European  Medicines Evaluation Agency EMEA has recommended...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Dec 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ciba+vision+corp..html"><![CDATA[CIBA Vision Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[New Investigational Data Presented On Rituxan Plus Chemotherapy as Potential Front-line Therapy]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Dec_5/ai_67580583]]></link>
		<description><![CDATA[Business Editors and Health/Medical Writers  SAN FRANCISCO--BUSINESS WIRE--Dec. 5, 2000  Low-Grade Non-Hodgkin's Lymphoma and Chronic Lymphocytic  Leukemia Studies Presented at ASH Meeting  Genentech, Inc. (NYSE: DNA) and IDEC (Nasdaq: IDEC) today announced positive preliminary data from small Phase II investigational studies examining the role of RituxanR...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Dec 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Bioenvision Readies Lead Product for Market; Reports Substantive Progress On Four Platform Technologies During Year Ended June 30, 2000]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Nov_15/ai_66953741]]></link>
		<description><![CDATA[Business Editors/Health Writers  NEW YORK--BUSINESS WIRE--Nov. 15, 2000  Bioenvision Inc, (OTCBB: BIOV), a development stage anti-cancer biopharmaceutical company, today reported a net loss of $1,495,509 for the fiscal year ended June 30, 2000.  The Company also stated that it intends to market Modrefen, its lead product, in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 15 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bioenvision+inc..html"><![CDATA[Bioenvision Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIVN</category>
		<category domain="tickers">BIVN</category>
	</item>
	<item>
		<title><![CDATA[Health Care Financing Administration Issues National Coverage Policy for Visudyne(TM) Therapy.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200011/ai_n22597689]]></link>
		<description><![CDATA[ATLANTA, GA, and VANCOUVER, BC, Nov 10, 2000    CIBA Vision Corporation, the eye care unit of Novartis AG (NYSE:  NVS), and QLT Inc. (NASDAQ: QLTI; TSE: QLT) today announced that the  Health Care Financing Administration HCFA has issued its national  coverage policy for VisudyneTM...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 10 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ciba+vision+corp..html"><![CDATA[CIBA Vision Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Health Care Financing Administration Issues National Coverage Policy For Visudyne Therapy.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200011/ai_n22597692]]></link>
		<description><![CDATA[ATLANTA and VANCOUVER, British Columbia, Nov 10, 2000    CIBA Vision Corporation, the eye care unit of Novartis AG (NYSE:  NVS), and QLT Inc. (Nasdaq: QLTI; Toronto) today announced that the  Health Care Financing Administration HCFA has issued its national  coverage policy for VisudyneTM (verteporfin...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 10 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ciba+vision+corp..html"><![CDATA[CIBA Vision Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Drug that treats leading cause of blindness wins Popular Science award.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200011/ai_n22597474]]></link>
		<description><![CDATA[ATLANTA, GA and VANCOUVER, BC, Nov 09, 2000    CIBA Vision, the eye care unit of Novartis AG (NYSE:NVS), and QLT  Inc. (NASDAQ: QLTI; TSE: QLT) announced today that VisudyneTM, their  breakthrough medical treatment for the leading cause of blindness in  people over the age...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 09 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ciba+vision+corp..html"><![CDATA[CIBA Vision Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[U.S. Physical Therapy, Ballantyne of Omaha, Riverdeep Group, American Business Financial Services, and EDAP TMS S.A. Conference Calls to be Broadcast On Investor Broadcast Network Over the Internet]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Nov_7/ai_66676543]]></link>
		<description><![CDATA[Business Editors/Hi-Tech Writers  PHILADELPHIA--BUSINESS WIRE--Nov. 7, 2000  U.S. Physical Therapy, Inc. (Nasdaq:USPH), Ballantyne of Omaha, Inc. (NYSE:BTN), Riverdeep Group plc (Nasdaq:RVDP), American Business Financial Services, Inc. (Nasdaq:ABFI) and EDAP TMS S.A. (Nasdaq:EDAPY)will broadcast their investor communication conference calls over the Internet, Investor Broadcast Network announced.  U.S. Physical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 07 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/edap+tms+s.a..html"><![CDATA[EDAP TMS S.A.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
		<category domain="tickers">EDAP</category>
	</item>
	<item>
		<title><![CDATA[[0] U.S. Physical Therapy, Ballantyne of Omaha, Riverdeep Group, American Business Financial Services, and EDAP TMS S.A. Conference Calls to be Broadcast On Investor Broadcast Network Over the Internet]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Nov_7/ai_66717514]]></link>
		<description><![CDATA[Business Editors/Hi-Tech Writers  PHILADELPHIA--BUSINESS WIRE--Nov. 7, 2000  U.S. Physical Therapy, Inc. (Nasdaq:USPH), Ballantyne of Omaha, Inc. (NYSE:BTN), Riverdeep Group plc (Nasdaq:RVDP), American Business Financial Services, Inc. (Nasdaq:ABFI) and EDAP TMS S.A. (Nasdaq:EDAPY) will broadcast their investor communication conference calls over the Internet, Investor Broadcast Network announced.  U.S....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 07 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/edap+tms+s.a..html"><![CDATA[EDAP TMS S.A.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
		<category domain="tickers">EDAP</category>
	</item>
	<item>
		<title><![CDATA[Bentley Pharmaceuticals Licenses New Patent for Treating Fibromyalgia and Chronic Fatigue Syndrome From Dartmouth College for Its Drug Delivery Program]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Nov_1/ai_66572691]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers  NORTH HAMPTON, N.H.--BUSINESS WIRE--Nov. 1, 2000  Bentley Pharmaceuticals, Inc. (AMEX:BNT), a drug delivery company with a commercial presence in Europe, announced today that it has signed a license with Dartmouth College obtaining exclusive rights to a patent covering novel use of androgen therapy...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/dartmouth+college.html"><![CDATA[Dartmouth College]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/syndrome.html"><![CDATA[syndrome]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[women]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[QLT announces positive skin cancer results.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200011/ai_n22596248]]></link>
		<description><![CDATA[VANCOUVER, Oct 31, 2000    QLT Inc. (NASDAQ: QLTI; TSE: QLT) today announced positive results  for its phase II study using photodynamic therapy with verteporfin to  treat non-melanoma skin cancer, the most common form of skin cancer in  the United States.    The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/qlt+inc..html"><![CDATA[QLT Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sutter Health Purchases Mediware's WORx for Pharmacy Solution]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Oct_30/ai_66573521]]></link>
		<description><![CDATA[Business Editors & Health/Medical Writers  LENEXA, Kan.--BW HealthWire--Oct. 30, 2000  Mediware Information Systems, Inc. (Nasdaq:MEDW), announced today that Sutter Health, one of Northern California's leading non-profit provider of health care services and programs, has purchased the WORxTM Drug Therapy Management System.  WORx is Mediware's industry-leading drug therapy...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Oct 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/mediware+information+systems+inc..html"><![CDATA[Mediware Information Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sutter+health.html"><![CDATA[Sutter Health]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDW</category>
		<category domain="tickers">MEDW</category>
	</item>
	<item>
		<title><![CDATA[EyeTech Pharmaceuticals and IOMED to Collaborate on the Delivery of Therapeutics to Treat Retinal Eye Diseases]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Oct_24/ai_66300203]]></link>
		<description><![CDATA[Health/Medical Writers  NEW YORK & SALT LAKE CITY--BW HealthWire--October 24, 2000  EyeTech Pharmaceuticals, Inc. and IOMED, Inc. (AMEX: IOX) today announced agreement on a collaborative effort to develop a non-invasive drug delivery system for EyeTech's investigational therapy targeting age-related macular degeneration AMD, the leading cause of blindness in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 Oct 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/iomed+inc..html"><![CDATA[IOMED Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Lorus Therapeutics Presents Anticancer Drug GTI-2040 At International Oncology Meeting In Greece]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Oct_19/ai_66206961]]></link>
		<description><![CDATA[Business Editors  TORONTO--BUSINESS WIRE--Oct. 19, 2000  Lorus (NASDAQ:LORFF)(TSE:LOR.)  Dr. Jim Wright to present at 5th World Congress on  Advances on Oncology and the 3rd International Symposium on  Molecular Medicine  Lorus Therapeutics Inc. ("Lorus") reported today that Dr. Jim Wright, president and chief scientific officer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 19 Oct 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/molecular+inc..html"><![CDATA[Molecular Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+chicago.html"><![CDATA[University of Chicago]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[QLT announces Visudyne(TM) sales for third quarter Company confident of continued strong growth in sales.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200010/ai_n22593200]]></link>
		<description><![CDATA[VANCOUVER, Oct 11, 2000    Following today's release of third quarter sales by Novartis  AG (NYSE: NVS), QLT Inc. (NASDAQ: QLTI; TSE: QLT) reported global  VisudyneTM therapy sales of U.S. $31 million (CDN $46.5 million or 53  million Swiss Francs) for the quarter ended September...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Oct 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ciba+vision+corp..html"><![CDATA[CIBA Vision Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/qlt+inc..html"><![CDATA[QLT Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[BIOSYNTECH Announces Successful Results of Preclinical Safety Evaluation of BST-GEL]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Sept_25/ai_65456754]]></link>
		<description><![CDATA[Business Editors  LAVAL, Quebec--BUSINESS WIRE--Sept. 25, 2000  BIOSYNTECH Inc. (OTCBB: BSYI) today announced it has successfully completed pre-clinical safety and evaluation studies of one of its lead products, BST-GELTM, an injectable, thermo-sensitive hydrogel for therapeutics delivery.  The studies showed BST-GELTM to have no systemic toxic effects at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Sep 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biomedical.html"><![CDATA[biomedical]]></category>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/deposit.html"><![CDATA[deposit]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
